• Like
  • Save
Geoff Mulgan on Austerity and Innovation - MaRS Global Leadership
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Geoff Mulgan on Austerity and Innovation - MaRS Global Leadership

  • 1,734 views
Published

Geoff Mulgan is recognized internationally as a leading speaker on social innovation and its successful realization. Very familiar with the pinch of austere budgets in the UK, Geoff will discuss the …

Geoff Mulgan is recognized internationally as a leading speaker on social innovation and its successful realization. Very familiar with the pinch of austere budgets in the UK, Geoff will discuss the opportunities society has to overcome the barriers that fiscal challenges present to innovation.

Following the 2008 global financial crisis Geoff laid out the challenges ahead during his 2009 TED Talk: “I think what connects the challenge for business, the challenge for government and the challenge for communities now, is both simple and difficult. We know our societies have to radically change. We know we can’t go back to where we were before. We know it’s only through experiment that we’ll discover exactly how to run a low carbon city, how to care for a much older population, how to deal with drug addiction – and so on.”

Published in Business , Technology , Education
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
1,734
On SlideShare
0
From Embeds
0
Number of Embeds
3

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. !"#$#%&()%*&)*+,-* * ./$&#"0&1**%2*3%%)4()%* * 5#)6*+/78%*
  • 2. ,A-?;,@A* FA.,<3<5*E* A::3@3A<@C*:?,* A+!F?C.>3F3BC* 3<=393=;.F-*E* <AA=-*?:* @?++;<3B3A-* .5A3<5*HAFF* C?;<5*!A?!FA* 3+!.@B*3<9A-B+A<B*9A<B;,A*3<9A-B3<5* :;<=*@.B.FC-3<5*-B.,B*;!* -;!!?,B3<5*.* -;!!?,B* =A9AF?!3<5*+.,GAB* ,A-A.,@D*E*!?F3@C* -93*:;<=* >35*-?@3ABC* ,A@?++A<=.B3?< :3<.<@A*:;<=* -*
  • 3. !)70I1*%2*,#$#"IJ* 3%4#$&K#%&*0%*0%%)4()%L*!"#$%&(% ,E=* 14.9 =#$08%* 22.1 ?"8%0$()%7* 26.1 0%%)4()%* B"0%0%8*E** 32.1 $M077$*2#4#7)NK#%&* -)TU"#* 20.2 2#4#7)NK#%&* O5)P&)PK"M#&Q* 14.5 ?&J#"*RI)N1"08J&L*#&IS* 3.5 B)&7* 133.4
  • 4. 3%%)4()%*$M077$* •  )*+,%-##*./0*#%12++-12324% •  53,#6,6%3,/+#-#7%4/8,+-/39% •  :*2#6/0*#/3%3/;,+%*<%=<+,,%8*%/-+>%4*623,9% •  :/1,%8*%</1,%8+/-#-#7% •  ?#%,@,/+#-#7%A3/B*+4C@DE% %
  • 5. @)%&"0V/()%*&)*N")2/I(40&1*8")U&JL** F$%&%G%%&(% L*8/3% &O(&% @/"*2+%N2/3-8;% )/A-8/3%L*8/3%</18*+%A+*6210.-8;% -#.,984,#8% HF% RS-6,+%",#,T89%*<% PO&(% -##*./0*#9U% &IF% K#.,984,#8%-#% OQJ% J(F% -##*./0*#% &F% )/A-8/3%-#.,984,#8% O(Q% K##*./0*#% -#.,984,#8% L:M% OP(% @/"*2+%N2/3-8;% ! " # $ Source: Innovation Index 6
  • 6. 3%4#$&K#%&*0%*0%%)4()%L*!"#$%&(%,E=* 14.9 !"#$"%&()*"#&+,&+"=#$08%* 22.1 L+/-#-#7% V+7%-##*.%?"8%0$()%7* 26.10%%)4()%* W,9-7#% E*XS/+,%B"0%0%8*E** YLD% 32.1$M077$*2#4#7)NK#%&* Z[W%-)TU"#* V8,+% 20.22#4#7)NK#%&*O5)P&)PK"M#&Q* 14.5?&J#"*RI)N1"08J&L*#&IS* 3.5 WXYWZ*)[*N"04&#*B)&7* 133.4 $#I&)"*)/&N/&* Source: Innovation Index 3
  • 7. Health spend as % GDP versus adult mortality rate % 16 15Health spend as % GDP 14 13 12 11 10 9 8 7 6 40 60 80 100 120 Adult mortality rate Source: OECD Health Data 2010
  • 8. Change in health spend share of GDP versus % improvement in adult mortality rate 3.0%% growth in share of GDP (p.a.) 2.5% 2.0% 1.5% 1.0% 0.5% 0.0% 0.0% 0.5% 1.0% 1.5% 2.0% 2.5% 3.0% 3.5% % improvement in mortality rate (p.a.)
  • 9. TraditionalWY !/"#*#I)%)K0#$*]%98*AA-#7%6*-#7%8-#79%$%/99,8%9/3,9%Y AI)%)K0#$*)[*&"0KK0%8*]%<+,,^,9$%,_1-,#1;%9/.-#79$%<*129% *#%,99,#0/39%]Y AI)%)K0#$*)[*2#71*]%8*%1/A-8/3$%A/;%+-9,9$%+,1+2-84,#8%
  • 10. OrganisationalXY*AI)%)K0#$*)[*$I7#*]%,7%/77+,7/0#7%1/33%1,#8+,9$%"/1`%*_1,%^Y*AI)%)K0#$*)[*$I)N#*]%,7%*#,%98*A%9*A9$%4230GA2+A*9,%A,+9*#/3% /6.-9,+9$%%1/A-8/3%-#8,7+/0*#$%/64-#-98+/0.,%1*#9*3-6/0*#%_Y*AI)%)K0#$*)[*`)U*]%,7%/28*4/0*#$%*9A-8/39%9A,1-/3-9-#7$% /77+,7/0*#%";%1*#6-0*#%%aYAI)%)K0#$*)[*N#%#&"()%*]%,7%98+,,8%1*#1-,+7,9$%203-0,9$%,#,+7;%%b*@0"I/0&*#I)%)K0#$*]%+,621-#7%</-32+,%6,4/#6%R*9A-8/3%+,A,/8,6%+,G /64-99-*#9UG%,7%E*1-/3%K4A/18%5*#69$%A+,.,#0.,%-#.,984,#8%4*6,39% %
  • 11. Relationalc  AI)%)K0#$*)[*"#$N)%$0V070&1*]%A/99-#7%+,9A*#9-"-3-8;%*28%8*%1-0^,#9% R,7%9,3<G8,90#7$%#,S%1/+7,9$%1*442#-8;%/99,8%8+/#9<,+U%Wd  AI)%)K0#$*)[*40$0V070&1*]%4*"-3-9-#7%A2"3-1%,;,9%RA2"3-1%1*#8+/189U% /#6%8,%A*S,+%*<%9/4,%R,7%92+7,+;%+/8,9U%WW  AI)%)K0#$*)[*"#8/7()%*%2*"0$M*e*/6/A0#7%/AA,08,9%<*+% +,723/0*#$%+,621-#7%-#9A,10*#$%1*4A3-/#1,%1*989%,81%W  AI)%)K0#$*)[*I)KK0&K#%&*]%9-X-#7%A+*.-9-*#%<+*4%3*S%8*%-7% 1*44-84,#8%A,*A3,%/#6%*+7/#-9/0*#9%R8/AA-#7%-#8*%,7%.*32#8,,+% 3/"*2+$%9*1-/3%,#8,+A+-9,$%4*0./0*#aU%
  • 12. TraditionalWY  !/"#*#I)%)K0#$*]%98*AA-#7%6*-#7%8-#79%$%/99,8%9/3,9%Y  AI)%)K0#$*)[*&"0KK0%8*]%<+,,^,9$%,_1-,#1;%9/.-#79$%<*129%*#%,99,#0/39%]Y  AI)%)K0#$*)[*2#71*]%8*%1/A-8/3$%A/;%+-9,9$%+,1+2-84,#8% Z,N2-+,%-##*./0*#% 4,8*69$%292/33;%/1+*99% Organisational *+7/#-9/0*#/3% "*2#6/+-,9%XY  AI)%)K0#$*)[*$I7#*]%,7%/77+,7/0#7%1/33%1,#8+,9$%"/1`%*_1,%^Y  AI)%)K0#$*)[*$I)N#*]%,7%*#,%98*A%9*A9$%4230GA2+A*9,%A,+9*#/3%/6.-9,+9$%%1/A-8/3%-#8,7+/0*#$%/64-#-98+/0.,% 1*#9*3-6/0*#%_Y  AI)%)K0#$*)[*`)U*]%,7%/28*4/0*#$%*9A-8/39%9A,1-/3-9-#7$%/77+,7/0*#%";%1*#6-0*#%%aY  AI)%)K0#$*)[*N#%#&"()%*]%,7%98+,,8%1*#1-,+7,9$%203-0,9$%,#,+7;%bY  @0"I/0&*#I)%)K0#$*]%+,621-#7%</-32+,%6,4/#6%R*9A-8/3%+,A,/8,6%+,G/64-99-*#9UG%,7%E*1-/3%K4A/18%5*#69$% A+,.,#0.,%-#.,984,#8%4*6,39%% Relational Z,N2-+,%+,8-#`-#7%8,% +,3/0*#9-A%",8S,,#%cY  AI)%)K0#$*)[*"#$N)%$0V070&1*]%A/99-#7%+,9A*#9-"-3-8;%*28%8*%1-0^,#9%R,7%9,3<G8,90#7$%#,S%1/+7,9$%1*442#-8;% A2"3-1%9,+.-1,9%/#6% /99,8%8+/#9<,+U% 1-0^,#9%%WdY AI)%)K0#$*)[*40$0V070&1*]%4*"-3-9-#7%A2"3-1%,;,9%RA2"3-1%1*#8+/189U%/#6%8,%A*S,+%*<%9/4,%%WWY A#I)%)K0#$*)[*"#8/7()%*%2*"0$M*e*/6/A0#7%/AA,08,9%<*+%+,723/0*#$%+,621-#7%-#9A,10*#$%1*4A3-/#1,%1*989% ,81%WY AI)%)K0#$*)[*I)KK0&K#%&*]%9-X-#7%A+*.-9-*#%<+*4%3*S%8*%-7%1*44-84,#8%A,*A3,%/#6%*+7/#-9/0*#9%R8/AA-#7 % -#8*%,7%.*32#8,,+%3/"*2+$%9*1-/3%,#8,+A+-9,$%4*0./0*#aU%
  • 13. WY*!")KN&$*[)"*0%%)4()%***
  • 14. !")KN&$*[)"*0%%)4()%* @)$&*#$I7()%** <#U*N#"$N#I(4#$*%2*0%$08J&$* :07/"#*2#K%2** @"0$#$*** <#U*#402#%I#*%2*&J#)"0#$* !")V7#K$** ;$#"*[##2VIM*** !)70(I7*K%2&#$* 5N$*0%*&J#*K"M#&***@KN08%$*%2*N#(()%$** <#U*&#IJ%)7)80#$** <#U*[/%20%8*N")8"KK#$** @)KN70%&$** =#K%2**** ;%K#&*%##2$**** ?NN)"&/%0(#$*** <#U*N"208K$*
  • 15. D)U*I%*U#*$1$&#K(I771*N")KN&*0%%)4()%f**F0&#"&/"#*"#40#U$** +"M#&*"#$#"IJ*** 3%&#"40#U$* B"#%2*$N)h%8***@)77#I(%8*%2* .I2#K0I*$&/20#$***%71$0%8*2&** -/"4#1$** :)"#$08J&*** D)"0i)%*$I%%0%8****-)I07*%2*#I)%)K0I*2&**** -I#%"0)*N7%%0%8**** :)I/$*8")/N$****** +N*$$#&$* 32#%([10%8*)NN)"&/%0(#$****;%2#"$&%20%8*N")V7#K$** @J77#%8#*$$/KN()%$**** ?V$#"4()%* .$M*206#"#%&*j/#$()%$****A&J%)8"NJ1 Community researchers -1$&#K*KNN0%8** +N*&J#*I/""#%&*$1$&#K**** 5#%#"(%8*0%$08J&$***+N*I/$&)K#"*g)/"%#1$* 3$$/#*&"##$* ,#["K#*N")V7#K$***
  • 16. Y*5#%#"(%8*02#$*%2*N")N)$7$**
  • 17. .0K*&)*8#%#"&#*F?B-*)[*02#$**OBJ#*U1*&)*8#&*8))2*02#$*0$*&)*8#&*7)&$*)[*02#$L*%2*>"0%$&)"K$*****&J")U*&J#*V2*)%#$*U1YQ* B,3k***** -."/()&"01&2()34" 56*.(71)"78*6(+"1)9" %(#:78*6(+""
  • 18. 5#%#"(%8*02#$*%2*N")N)$7$**** 32#$*K"M#&N7I#$***** :#$(47$*%2*IKN$****** @)KN#(()%$*%2*N"0i#$**** @")U2P$)/"I0%8******* 3%I#%(4#$***** -M/%MU)"M$******* @)77V)"(4#*#%j/0"1****** -(K/7(%8*&J0%M0%8** @"#(4#*&J0%M0%8*&))7$***** <#&U)"M0%8******>"0%$&)"K$***** ."($&$l&J0%M#"$*0%*"#$02#%I#****** =#4#7)N0%8*02#$** B,3k***** ;$#"P7#2*2#$08%***** BJ#)"1*)[*IJ%8#****** .*&#K$****** =#$08%*&))7$*****
  • 19. !"0i#$*%2*0%I#%(4#$****** YYY&)*"#2/I0%8*I"V)%* #K0$$0)%$*** * @)77V)"(4#* #%j/0"1******:")K*K#$/"0%8*7)%80&/2#YYY*** =#$08%*&))7$*******
  • 20. ]Y*!")&)&1N#$*%2*&#$(%8**
  • 21. !")&)&1N#$*%2*&#$(%8** !")2/I&l$#"40I#lN")I#$$*2#$08%********* @)$&*V#%#m&*K)2#770%8************* =#$08%************ ,#7()%$J0N*KNN0%8************@)P2#$08%************ !")&)&1N0%8** >7/#PN"0%(%8*********** ,N02*!")&)&1N0%8********** !"))[*)[*I)%I#N&********** +"M#&*&#$(%8********** -0K/7()%$********* >/$0%#$$*I$#$*********** B"07$*** AnN#"0K#%&7*i)%#$******** !&Jm%2#"$******* ?N#%*&#$(%8********* >#&*&#$(%8******** !07)&$****** A47/()%***********
  • 22. <#$&*J$*2#4#7)N#2*&))7$*%2*N")I#$$#$*&J&*%1)%#*I%*/$#*&)*2#4#7)N*%2*&#$&**$#"40I#*02#*% =#$08%*&))7$*****
  • 23. :)"K7*N07)&$*%2*&#$&$* =#$08%*&))7$*****
  • 24. @)$&*V#%#m&*K)2#770%8* Step 1: Identify all Step 3: Estimate the inputs to the service costs of all the inputs Cost figure = Unit cost Activity measure Step 4: Calculate the Step 2: Identify all unit cost outputs to the service D)U*0$*0&**V#o#"*/$#*)[* "#$)/"I#f*
  • 25. XY*-/$&0%0%8*%2*#KV#220%8**
  • 26. ****-/$&0%0%8*%2*#KV#220%8* !/V70I*"#8/7()%*********** F#2#"$J0N*%2*8)4#"%%I#*********** ?"8%0$()%*%2** !)70I1** K%8#K#%&*K)2#7$** I)KK0&K#%&** @)77V)"(4#* -M077*%2*INI0&1*2#4#7)NK#%&*********** #%j/0"1****** =#$08%0%8*&#K$*********** >"0%$&)"K$***** 9#%&/"#*m%%I#** >/$0%#$$*K)2#7$*** F)%$L*#j/0&1*%2*j/$0P#j/0&1** @")U2*[/%20%8* 5"%&$*[)"*8")U&J************ *********** !")8"KK#*[/%20%8*********** =#$08%*&))7$***** -)I07*3KNI&*>)%2$*
  • 27. +)"#*$1$&#K(I*K#$/"#K#%&L* $$#$$K#%&L*#47/()%*
  • 28. Slide 37
  • 29. ^Y*5")U0%8*%2*$I70%8***
  • 30. **** 5")U0%8*%2*$I70%8**5")U0%8*%*)"8%0$()%* F0I#%$0%8************* ***********)"*4#%&/"#** +#"8#"$*%2*Ij/0$0()%$**************:#2#"()%$*%2*IJ0%$************** @)N10%8*************** @)77V)"(4#* :"%IJ0$0%8***** ********* .2)N(%8*********** #%j/0"1****** -&)"1&#770%8*********** =0$$#K0%()%*************>"0%$&)"K$***** >")2I$(%8*********** @KN08%0%8*********** <#&U)"M0%8************B"0%0%8*************** ** @J%80%8*V#J40)/"*** 3%I#%(4#$************* @)IJ0%8************** *********** .24#"($0%8************ ?N#%*$)/"I#************* <#&U)"M0%8************* =#$08%*&))7$*****
  • 31. DATA JP%
  • 32. :0%%I#*[)"*8")U0%8*$)I07*0%%)4()%$** :*2#6/0*#9% % % Y*.,+#4,#8% Social impact bonds )+*S6<2#6-#7% % % % %
  • 33. Doubling level of academicresults in 2 years
  • 34. =06#"#%&*U1$*&)*$I7#*4Y** >/$0%#$$* :"%IJ0$0%8* F0I#%$0%8* 8")U&J*
  • 35. _Y*-1$&#K0I*IJ%8#*
  • 36. -1$&#K0I*IJ%8#**B)*8#&*[")K*J#"#YYY* YYY&)*J#"#YYY*YYYK%1*&J0%8$*%##2*&)*IJ%8#*0%*&%2#K**
  • 37. B"%$[)"K0%8**$1$&#K*<#U*&#IJ%)7)80#$L* ,#I70V"&#2*N")2/I&$*%2* K"M#&$*$#"40I#$**<#U*N)70I0#$*%2* >#J40)/"7*"#8/7()%$* IJ%8#*
  • 38. B"%$[)"K0%8**$1$&#K*<#U*&#IJ%)7)80#$L*N")2/I&$*%2* ,#I70V"&#2*K"M#&$*$#"40I#$** Age Unlimited Scotland People Powered Health !<#U*N)70I0#$*%2*"#8/7()%$* >#J40)/"7*IJ%8#*
  • 39. 5?.F-* $&"&#80I* Strategy Units Prizes Skunk worksPARTICIPANTS 0%&#"%7**#n&#"%7* accelerators Idea Factory Collaboratives )N#%*
  • 40. Cost Boomerang; early savings, higher long-term costs dynamic savings Slide 50 Time
  • 41. -&8#$*)[* ;%2#"$&%20%8* 32#()%L* !07)&$L* -/$&0%0%8L* -I70%8*0%%)4()%* N")V7#K$L* 8#%#"(%8* N")&)&1N#$L* #KV#220%8* )NN)"&/%0(#$* )N()%$* &#$&$*A402#%I#* bcA3*+/8*+;$% W+/S-#7%*#% M3/29-"3,% )3,/+% E8+*#7%"#j/0"#2* 1*4A+,,#9-., ,.-6,#1,%"28% /11*2#8%*<% ,.-6,#1,%*<% ,.-6,#1,$% <*+4/3%/#6% #*8%%*.,+3;% *S%-4A/18% -4A/18$%6/8/% 1*#T+4,6% ,4,+7-#7% 1*#98+/-#,6d% 1*236%",% 7,#,+/0*#$% 8+*27% `#*S3,67,% ;"+-69d% /1-,.,6% ./3-6/0*#% 4230A3,% /99,4"3-,9d% 29-#7% +,9,/+1%8**39% 29,+% ,.-6,#1,$% -#1O%Z)L% ,#7/7,4,#8% A+/100*#,+% `#*S3,67,% ,81%:0%%I#* e,+;%3*S$% E4/33%9249d% D*6,+/8,d% E-7#-T1/#8f% @/+7,f%"#j/0"#2* 7+/#89$%*A,#% 7+/#89$% 7+/#89d% A+*7+/44,$% A+*7+/44,$% 1*#.,+0"3,% 1*#.,+0"3,d% ,N2-8;$%3*/#9% ,N2-8;$%3*/#9$% 98/7,G7/8,% M5Z$%EK59%,0$M* #C/% g-7%+-9`% g-7%+-9`$%"28% D,6-24%+-9`% @*S%+-9`%J%270%8* /AA,08,$%/#6% 4,/92+,9%8*% /AA,08,d%% /AA,08,d%% 3-`,3;%</-32+,% 6,G+-9`f% 91*A,%<*+% 98+*#7% +/8,% -4A3,4,#8/0 /6/A8/0*#d% 1/A/1-8;d% *#%1/A/1-8;% +,.,+9-"-3-8;d% T6,3-8;%% ,81% 1*-1,%